Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
NYS Entity Status
NYS Filing Date
DECEMBER 31, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2013 - INOUYE & OGDEN LLC
Around the Web
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Syrian grandma at center of travel ban lawsuit arrives in Hawaii
By Mark Moore - Sunday Aug 13, 2017
The Syrian grandmother at the center of Hawaii’s lawsuit challenging President Trump’s travel ban arrived in Honolulu late Saturday, according to a report. Wafa Yahia, 52, who got approval from the US government several weeks ago, arrived at Daniel K. Inouye International Airport after a 28-hour journey that began in Lebanon, the Associated Press reported...
- Vegas massacre survivors memorialize event with tattoos
By Associated Press - Tuesday Oct 31, 2017
OGDEN, Utah — Four Utah women who survived a mass shooting at a Las Vegas country music festival are memorializing their experiences with matching tattoos. Laura Farthing, Shelley Burch, Lori Wilson and Alyssa Hodges took a trip to Las Vegas to enjoy the Route 91 Harvest festival earlier this month. The four women wound up...
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]